| Jessica Koerner, | |
|
2220 Canterbury Dr, Hays, KS 67601-2370 | |
| (785) 623-5850 | |
| Not Available |
| Full Name | Jessica Koerner |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2220 Canterbury Dr, Hays, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669977393 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-14193 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Koerner, 2220 Canterbury Dr, Hays, KS 67601-2370 Ph: () - | Jessica Koerner, 2220 Canterbury Dr, Hays, KS 67601-2370 Ph: (785) 623-5850 |
News Archive
CBS News: "With the clock ticking on Senate Democrats' efforts to draw up a health care bill they all can agree on before the end of the year, Senate leaders on Monday said they would commit to providing seniors with better prescription drug coverage through Medicare." Senate Majority Leader Harry Reid, D-Nev., pledged to close a gap - known as the "doughnut hole" - in Medicare's drug coverage.
An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.
Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc. have announced that Takeda's intellectual property rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS (pioglitazone HCl).
According to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant sides effects.
A counterintuitive experiment has resulted in one of the longest recorded life-span extensions in any organism and opened a new door for anti-aging research in humans.
› Verified 2 days ago
Mr. Gregory E Bethel, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Vine St, Hays, KS 67601 Phone: 785-628-1767 | |
Morgan Whitmore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4301 Vine St, Hays, KS 67601 Phone: 785-625-0037 | |
Mr. Arthur Spalsbury, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1902 Vine St, Hays, KS 67601 Phone: 785-628-6148 | |
James Meier, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5850 | |
William Albert Cadoret, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5000 Fax: 785-623-5854 | |
Shawn Giess, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5850 | |
Dr. Jeremy Snyder, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Vine St, Hays, KS 67601 Phone: 785-628-1767 |